The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)
Participants with confirmed Sickle Cell Disease.
Participants 6 months and 6 years of age and due for measles vaccination within 3 months per national guidelines.
Willing and able to provide informed consent
Ability to comply with study related evaluations and follow-up visits.
None
Children's Hospital Medical Center, Cincinnati
Lead sponsor
Thrasher Research Fund
Collaborator
National Institutes of Health (NIH)
Collaborator